Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Protein kinase A – CREB pathway** is a canonical signal transduction pathway in which **cyclic AMP-dependent protein kinase A (PKA)** phosphorylates the **cAMP response element-binding protein (CREB)** at Ser133, activating its transcription factor function[1][3][4][5]. Activated CREB recruits the co-activators **CBP/p300**, enabling transcription of genes involved in **cell growth, survival, differentiation, metabolism, immune regulation, and neuronal plasticity**[1][3]. Dysregulation of this pathway contributes to tumorigenesis by promoting proliferation, resisting apoptosis, and enabling immune evasion, and also plays key roles in neuronal and hematopoietic physiology[2][6][5]. Targeting the PKA–CREB–CBP interface is considered a promising but challenging therapeutic strategy, with small molecules such as KG-501 and naphthol derivatives explored experimentally[2][4]. The pathway is often measured by assessing CREB phosphorylation and activity, which serve as potential biomarkers in multiple disease contexts[4][6][5].\n\n**Note:** The request for information about "Protein kinase A – CREB pathway" does not refer to a single molecular entity, but rather a signaling axis composed of **multiple proteins** (enzyme and transcription factor), making direct mapping to the conventions for drug targets difficult. In structured databases, separate entries exist for "Protein kinase A" (PKA) and "cAMP response element-binding protein" (CREB), not the pathway as a whole.
Direct inhibition of CREB–CBP/p300 interaction, blocking transcriptional coactivator recruitment - Inhibition of CREB phosphorylation at Ser133 via PKA antagonists - Modulation of cAMP signaling upstream (Adenosine receptor antagonism) - Inhibition of CREB–DNA binding, blocking downstream gene transcription - Promoting CREB protein degradation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase A – cAMP response element-binding protein pathway (PKA–CREB pathway).